Compounds > quinacrine

quinacrine and albendazole

quinacrine has been researched along with albendazole in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (25.00)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Chakraborty, PR; Edlind, TD; Hang, TL1
Meyer, EK1
Dardick, KR1
Hanevik, K; Langeland, N; Mørch, K; Robertson, LJ; Strand, EA1
Lachish, T; Meltzer, E; Schwartz, E1
Armstrong, M; Chiodini, PL; Lever, RA; Nabarro, LE1
Carter, ER; Chiodini, PL; Hedley, L; Nabarro, LE1
Hanevik, K; Mørch, K1
Bottieau, E; Hatz, C; Kuenzli, E; Mechain, M; Mørch, K; Neumayr, A; Rothe, C; Schunk, M; Soriano Pérez, MJ; Sothmann, P; Sydow, V; Theunissen, C; Van Esbroeck, M1

Reviews

2 review(s) available for quinacrine and albendazole

ArticleYear
Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:1

    Topics: Albendazole; Antiprotozoal Agents; Chloroquine; Drug Resistance; Drug Therapy, Combination; Giardia lamblia; Giardiasis; Humans; Metronidazole; Quinacrine; Tinidazole; Treatment Failure

2018
Giardiasis treatment: an update with a focus on refractory disease.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:5

    Topics: Adult; Albendazole; Antiprotozoal Agents; Benzimidazoles; Child; Diarrhea; Drug Resistance; Drug Therapy, Combination; Female; Giardia; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Nitroimidazoles; Quinacrine

2020

Other Studies

10 other study(ies) available for quinacrine and albendazole

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro.
    The Journal of infectious diseases, 1990, Volume: 162, Issue:6

    Topics: Albendazole; Animals; Dose-Response Relationship, Drug; Drug Resistance; Giardia; Mebendazole; Metronidazole; Quinacrine; Thiabendazole

1990
Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs.
    Journal of the American Veterinary Medical Association, 1998, Jul-01, Volume: 213, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Fenbendazole; Giardiasis; Metronidazole; Pharmacopoeias as Topic; Quinacrine; United States; United States Food and Drug Administration

1998
Re: Letter on quinacrine for treatment of Giardiasis--J Travel Med 1998;5:228.
    Journal of travel medicine, 1999, Volume: 6, Issue:4

    Topics: Albendazole; Antinematodal Agents; Antiprotozoal Agents; Giardiasis; Humans; Quinacrine

1999
Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.
    The Journal of infection, 2008, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Albendazole; Algorithms; Animals; Antimalarials; Antiprotozoal Agents; Disease Outbreaks; Drug Therapy, Combination; Feces; Female; Giardia; Giardiasis; Humans; Male; Metronidazole; Middle Aged; Norway; Paromomycin; Polymerase Chain Reaction; Quinacrine; Treatment Outcome

2008
Treatment of giardiasis after nonresponse to nitroimidazole.
    Emerging infectious diseases, 2014, Volume: 20, Issue:10

    Topics: Adult; Albendazole; Animals; Antiparasitic Agents; Female; Giardia lamblia; Giardiasis; Humans; Male; Nitroimidazoles; Paromomycin; Quinacrine; Young Adult

2014
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015, Volume: 21, Issue:8

    Topics: Adult; Albendazole; Antiprotozoal Agents; Drug Resistance; Female; Giardia lamblia; Giardiasis; Hospitals; Humans; Incidence; London; Male; Nitro Compounds; Nitroimidazoles; Quinacrine; Retrospective Studies; Thiazoles; Travel; Treatment Failure

2015
Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-20, Volume: 73, Issue:8

    Topics: Albendazole; Antiprotozoal Agents; Chloroquine; Giardia lamblia; Giardiasis; Humans; Nitroimidazoles; Prospective Studies; Quinacrine

2021